{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:42:54Z","timestamp":1777275774178,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308590\/2017-1"],"award-info":[{"award-number":["308590\/2017-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["446274\/2014-3"],"award-info":[{"award-number":["446274\/2014-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.10.012","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T06:17:05Z","timestamp":1539238625000},"page":"1670-1678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["SB-83, a 2-Amino-thiophene derivative orally bioavailable candidate for the leishmaniasis treatment"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-3529","authenticated-orcid":false,"given":"Klinger Antonio da Franca","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiana Karla Frade","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa de Lima","family":"Serafim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia N\u00e9ris","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano Francisco","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner Luis","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatianne Mota","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivianne Mendes","family":"Mangueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna Vieira","family":"Sobral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Ol\u00edmpio de","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Jaime Bezerra","family":"Mendon\u00e7a Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Rosa de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.10.012_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.biopha.2018.10.012_bib0010","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1371\/journal.pntd.0001612","article-title":"In vitro and in vivo efficacy of ether lipid Edelfosine against Leishmania spp. and SbV-resistant parasites","volume":"6","author":"Varela-M","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2018.10.012_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41182-016-0002-0","article-title":"Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review","volume":"44","author":"Hashiguchi","year":"2016","journal-title":"Trop. Med. Health."},{"key":"10.1016\/j.biopha.2018.10.012_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.actatropica.2017.04.029","article-title":"Application of nanotechnology in treatment of leishmaniasis: a review","volume":"172","author":"Akbari","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2018.10.012_bib0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2013 current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.10.011","article-title":"2-amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro","volume":"106","author":"da F Rodrigues","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.10.012_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081492","article-title":"In vitro susceptibilities of wild and drug resistant Leishmania donovani amastigote stages to andrographolide nanoparticle: role of vitamin E derivative TPGS for nanoparticle efficacy","volume":"8","author":"Mondal","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.biopha.2018.10.012_bib0045","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.ejmech.2010.09.059","article-title":"Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4,5,6,7-tetrahydro-N- phenylbenzo[b]thiophene-3-carboxamide","volume":"45","author":"Amr","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.10.012_bib0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.exppara.2013.07.007","article-title":"Neolignan licarin a presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro","volume":"135","author":"N\u00e9ris","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopha.2017.03.049","article-title":"A new acridine derivative induces cell cycle arrest and antiangiogenic effect on Ehrlich ascites carcinoma model","volume":"90","author":"Mangueira","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.10.012_bib0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.157.2.827","article-title":"Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication","volume":"157","author":"Vieira","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0031182005008073","article-title":"Germ-free mice produce high levels of interferon-gamma in response to infection with Leishmania major but fail to heal lesions","volume":"131","author":"Oliveira","year":"2005","journal-title":"Parasitology."},{"key":"10.1016\/j.biopha.2018.10.012_bib0070","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2018.10.012_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00436-010-1852-8","article-title":"Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species","volume":"107","author":"Liarte","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.biopha.2018.10.012_bib0080","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2017.08.096","article-title":"In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative","volume":"95","author":"de Almeida","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.10.012_bib0085","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.biopha.2018.07.056","article-title":"Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies","volume":"106","author":"da Trindade Granato","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.10.012_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpddr.2016.12.002","article-title":"Therapeutic effect of ursolic acid in experimental visceral leishmaniasis","volume":"7","author":"Jesus","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.biopha.2018.10.012_bib0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.fct.2016.10.023","article-title":"Safety evaluation of substituted thiophenes used as flavoring ingredients","volume":"99","author":"Cohen","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0100","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00204-011-0738-6","article-title":"A comprehensive review about micronuclei: mechanisms of formation and practical aspects in genotoxicity testing","volume":"85","author":"Bolt","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jep.2012.01.059","article-title":"Review of current and \u201comics\u201d methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms","volume":"140","author":"Ouedraogo","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bjan.2013.07.006","article-title":"Evaluation of genotoxicity induced by repetitive administration of local anaesthetics: an experimental study in rats","volume":"65","author":"Nai","year":"2015","journal-title":"Brazilian J. Anesthesiol. English Ed."},{"key":"10.1016\/j.biopha.2018.10.012_bib0115","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00436-012-3028-1","article-title":"Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis","volume":"111","author":"Valadares","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.biopha.2018.10.012_bib0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00156","article-title":"Interferon Gamma in Leishmaniasis","volume":"4","author":"Kima","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijpara.2003.11.021","article-title":"The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds","volume":"34","author":"Gumy","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.62876","article-title":"Immunological perspectives of leishmaniasis","volume":"2","author":"Nyl\u00e9n","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.10.012_bib0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0140","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2018.10.012_bib0145","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.biopha.2018.10.012_bib0150","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.159.7.3490","article-title":"IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages","volume":"159","author":"Puddu","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0155","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1017\/S0031182016001086","article-title":"Treatment with synthetic lipophilic tyrosyl ester controls Leishmania major infection by reducing parasite load in BALB\/c mice","volume":"143","author":"Sghaier","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2018.10.012_bib0160","doi-asserted-by":"crossref","DOI":"10.1590\/S0102-695X2007000400018","article-title":"Estudo toxicol\u00f3gico pr\u00e9-cl\u00ednico agudo com o extrato hidroalco\u00f3lico das folhas de Cissus sicyoides L. (Vitaceae)","volume":"17","author":"de Vasconcelos","year":"2007","journal-title":"Rev. Bras. Farmacogn."},{"key":"10.1016\/j.biopha.2018.10.012_bib0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: newer developments","volume":"4","author":"Mohapatra","year":"2014","journal-title":"Trop. Parasitol."},{"key":"10.1016\/j.biopha.2018.10.012_bib0170","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1016\/j.bmc.2016.04.057","article-title":"Antileishmanial activity of new thiophene\u2013indole hybrids: design, synthesis, biological and cytotoxic evaluation, and chemometric studies","volume":"24","author":"F\u00e9lix","year":"2016","journal-title":"Bioorg. Med. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218351734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218351734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:49:22Z","timestamp":1777272562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218351734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":34,"alternative-id":["S0753332218351734"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.012","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SB-83, a 2-Amino-thiophene derivative orally bioavailable candidate for the leishmaniasis treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}